Alto Neuroscience vs iQure Pharma .
Alto Neuroscience vs iQure Pharma ., compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alto Neuroscience is on 43/100 and iQure Pharma . on 39/100.
Where each one leads
Alto Neuroscience
- our overall score: 43/100 against 39/100
- agent readiness: 48/100 against 21/100
- domain rating: 44/100 against 10/100
- headcount: 86 against 9
- LinkedIn following: 24,482 against 671
iQure Pharma .
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Alto Neuroscience | iQure Pharma . |
|---|---|---|
| What it is | Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions. | Restores glutamate homeostasis by targeting astrocyte biology, breaking the cycle of excitotoxicity across CNS diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, HealthTech, Drug Discovery, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2019 | 2017 |
| Headquarters | Los Altos, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alto Neuroscience | iQure Pharma . |
|---|---|---|
| Employees | 86 | 9 |
| Total funding | $370M | Not published |
| Latest round | Registered Direct Offering | Not published |
| LinkedIn followers | 24,482 | 671 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alto Neuroscience | iQure Pharma . |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 39/100 |
| Traction | 59/100 | 10/100 |
| Community | 13/100 | Not published |
| Search visibility | 35/100 | 34/100 |
| Quality | 45/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alto Neuroscience | iQure Pharma . |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery, PHP |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Alto Neuroscience vs iQure Pharma .: common questions
Which is better, Alto Neuroscience or iQure Pharma .?
On our 0-100 score Alto Neuroscience rates higher (43/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Alto Neuroscience and iQure Pharma . compare on the numbers?
Alto Neuroscience leads on our overall score (43/100 against 39/100), agent readiness (48/100 against 21/100), domain rating (44/100 against 10/100), headcount (86 against 9), LinkedIn following (24,482 against 671).
Read the full Alto Neuroscience review and pricing or the iQure Pharma . review and pricing. You can also browse other Alto Neuroscience alternatives we track.